TGLVY
Price
$1.14
Change
+$0.08 (+7.55%)
Updated
Dec 19 closing price
TRUMY
Price
$19.37
Change
+$0.05 (+0.26%)
Updated
Dec 20 closing price
45 days until earnings call
Ad is loading...

TGLVY vs TRUMY

Header iconTGLVY vs TRUMY Comparison
Open Charts TGLVY vs TRUMYBanner chart's image
Top Glove
Price$1.14
Change+$0.08 (+7.55%)
Volume$868
CapitalizationN/A
Terumo
Price$19.37
Change+$0.05 (+0.26%)
Volume$80.55K
CapitalizationN/A
TGLVY vs TRUMY Comparison Chart
Loading...
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TGLVY vs. TRUMY commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGLVY is a Hold and TRUMY is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (TGLVY: $1.14 vs. TRUMY: $19.37)
Brand notoriety: TGLVY and TRUMY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TGLVY: 44% vs. TRUMY: 113%
Market capitalization -- TGLVY: $1.65B vs. TRUMY: $24.6B
TGLVY [@Medical Specialties] is valued at $1.65B. TRUMY’s [@Medical Specialties] market capitalization is $24.6B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGLVY’s FA Score shows that 2 FA rating(s) are green whileTRUMY’s FA Score has 1 green FA rating(s).

  • TGLVY’s FA Score: 2 green, 3 red.
  • TRUMY’s FA Score: 1 green, 4 red.
According to our system of comparison, TGLVY is a better buy in the long-term than TRUMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGLVY’s TA Score shows that 6 TA indicator(s) are bullish while TRUMY’s TA Score has 4 bullish TA indicator(s).

  • TGLVY’s TA Score: 6 bullish, 4 bearish.
  • TRUMY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TGLVY is a better buy in the short-term than TRUMY.

Price Growth

TGLVY (@Medical Specialties) experienced а +7.55% price change this week, while TRUMY (@Medical Specialties) price change was -2.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

TRUMY is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRUMY($24.6B) has a higher market cap than TGLVY($1.65B). TRUMY has higher P/E ratio than TGLVY: TRUMY (38.46) vs TGLVY (27.25). TGLVY YTD gains are higher at: 62.857 vs. TRUMY (19.204). TRUMY has higher annual earnings (EBITDA): 185B vs. TGLVY (-122.26M). TRUMY has more cash in the bank: 163B vs. TGLVY (988M). TGLVY has less debt than TRUMY: TGLVY (654M) vs TRUMY (232B). TRUMY has higher revenues than TGLVY: TRUMY (798B) vs TGLVY (2.77B).
TGLVYTRUMYTGLVY / TRUMY
Capitalization1.65B24.6B7%
EBITDA-122.26M185B-0%
Gain YTD62.85719.204327%
P/E Ratio27.2538.4671%
Revenue2.77B798B0%
Total Cash988M163B1%
Total Debt654M232B0%
FUNDAMENTALS RATINGS
TGLVY vs TRUMY: Fundamental Ratings
TGLVY
TRUMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
89100
PRICE GROWTH RATING
1..100
3647
P/E GROWTH RATING
1..100
275
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGLVY's Valuation (11) in the null industry is in the same range as TRUMY (19). This means that TGLVY’s stock grew similarly to TRUMY’s over the last 12 months.

TRUMY's Profit vs Risk Rating (74) in the null industry is in the same range as TGLVY (100). This means that TRUMY’s stock grew similarly to TGLVY’s over the last 12 months.

TGLVY's SMR Rating (89) in the null industry is in the same range as TRUMY (100). This means that TGLVY’s stock grew similarly to TRUMY’s over the last 12 months.

TGLVY's Price Growth Rating (36) in the null industry is in the same range as TRUMY (47). This means that TGLVY’s stock grew similarly to TRUMY’s over the last 12 months.

TGLVY's P/E Growth Rating (2) in the null industry is significantly better than the same rating for TRUMY (75). This means that TGLVY’s stock grew significantly faster than TRUMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGLVYTRUMY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
66%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 27 days ago
80%
Bearish Trend 5 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
65%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Ad is loading...
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX32.870.47
+1.45%
Eventide Healthcare & Life Sciences N
GSVUX16.730.19
+1.15%
Goldman Sachs Large Cap Value R6
GEFPX13.800.15
+1.10%
Gotham Enhanced 500 Plus Institutional
ODIIX127.571.07
+0.85%
Invesco Discovery R6
NQGAX34.500.24
+0.70%
Nuveen Global Equity Income A

TGLVY and

Correlation & Price change

A.I.dvisor tells us that TGLVY and BNR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TGLVY and BNR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGLVY
1D Price
Change %
TGLVY100%
N/A
BNR - TGLVY
20%
Poorly correlated
+6.99%
TRXO - TGLVY
13%
Poorly correlated
N/A
SSMXY - TGLVY
12%
Poorly correlated
+0.21%
VPTDF - TGLVY
8%
Poorly correlated
-3.41%
TRUMY - TGLVY
3%
Poorly correlated
+0.26%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
+0.26%
HOCPY - TRUMY
51%
Loosely correlated
-1.26%
SSMXY - TRUMY
45%
Loosely correlated
+0.21%
SMTI - TRUMY
43%
Loosely correlated
+6.62%
OLYMY - TRUMY
40%
Loosely correlated
+2.71%
AZTA - TRUMY
39%
Loosely correlated
+1.88%
More